143 related articles for article (PubMed ID: 18385943)
1. The JNK/AP1/ATF2 pathway is involved in H2O2-induced acetylcholinesterase expression during apoptosis.
Zhang JY; Jiang H; Gao W; Wu J; Peng K; Shi YF; Zhang XJ
Cell Mol Life Sci; 2008 May; 65(9):1435-45. PubMed ID: 18385943
[TBL] [Abstract][Full Text] [Related]
2. Involvement of JNKs and p38-MAPK/MSK1 pathways in H2O2-induced upregulation of heme oxygenase-1 mRNA in H9c2 cells.
Aggeli IK; Gaitanaki C; Beis I
Cell Signal; 2006 Oct; 18(10):1801-12. PubMed ID: 16531007
[TBL] [Abstract][Full Text] [Related]
3. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation of scavenger receptor expression in human smooth muscle cells requires AP-1/c-Jun and C/EBPbeta: both AP-1 binding and JNK activation are induced by phorbol esters and oxidative stress.
Mietus-Snyder M; Glass CK; Pitas RE
Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1440-9. PubMed ID: 9743233
[TBL] [Abstract][Full Text] [Related]
5. Amino-terminal-derived JNK fragment alters expression and activity of c-Jun, ATF2, and p53 and increases H2O2-induced cell death.
Buschmann T; Yin Z; Bhoumik A; Ronai Z
J Biol Chem; 2000 Jun; 275(22):16590-6. PubMed ID: 10748185
[TBL] [Abstract][Full Text] [Related]
6. The role of c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase in insulin-induced Thr69 and Thr71 phosphorylation of activating transcription factor 2.
Baan B; van Dam H; van der Zon GC; Maassen JA; Ouwens DM
Mol Endocrinol; 2006 Aug; 20(8):1786-95. PubMed ID: 16601071
[TBL] [Abstract][Full Text] [Related]
7. The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair.
Hayakawa J; Depatie C; Ohmichi M; Mercola D
J Biol Chem; 2003 Jun; 278(23):20582-92. PubMed ID: 12663670
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of ATF2 and interaction with NFY induces c-Jun in the gonadotrope.
Lindaman LL; Yeh DM; Xie C; Breen KM; Coss D
Mol Cell Endocrinol; 2013 Jan; 365(2):316-26. PubMed ID: 23178797
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
[TBL] [Abstract][Full Text] [Related]
10. Growth factor stimulation induces cell survival by c-Jun. ATF2-dependent activation of Bcl-XL.
Salameh A; Galvagni F; Anselmi F; De Clemente C; Orlandini M; Oliviero S
J Biol Chem; 2010 Jul; 285(30):23096-104. PubMed ID: 20507983
[TBL] [Abstract][Full Text] [Related]
11. MEKK1-MKK4-JNK-AP1 pathway negatively regulates Rgs4 expression in colonic smooth muscle cells.
Zhang Y; Li F; Liu S; Wang H; Mahavadi S; Murthy KS; Khalili K; Hu W
PLoS One; 2012; 7(4):e35646. PubMed ID: 22545125
[TBL] [Abstract][Full Text] [Related]
12. Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1.
Diefenbacher M; Sekula S; Heilbock C; Maier JV; Litfin M; van Dam H; Castellazzi M; Herrlich P; Kassel O
Mol Endocrinol; 2008 Aug; 22(8):1767-80. PubMed ID: 18535250
[TBL] [Abstract][Full Text] [Related]
13. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and MAPK involved into ATF2 expression in immortalized human urothelial cells treated by arsenic.
Liu S; Wang F; Yan L; Zhang L; Song Y; Xi S; Jia J; Sun G
Arch Toxicol; 2013 Jun; 87(6):981-9. PubMed ID: 23591579
[TBL] [Abstract][Full Text] [Related]
15. The unfolded protein response and the phosphorylations of activating transcription factor 2 in the trans-activation of il23a promoter produced by β-glucans.
Rodríguez M; Domingo E; Alonso S; Frade JG; Eiros J; Crespo MS; Fernández N
J Biol Chem; 2014 Aug; 289(33):22942-22957. PubMed ID: 24982422
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma protein interacts with ATF2 and JNK/p38 in stimulating the transforming growth factor-beta2 promoter.
Li H; Wicks WD
Arch Biochem Biophys; 2001 Oct; 394(1):1-12. PubMed ID: 11566021
[TBL] [Abstract][Full Text] [Related]
17. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.
Muniyappa H; Das KC
Cell Signal; 2008 Apr; 20(4):675-83. PubMed ID: 18222647
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress activates the human histidine decarboxylase promoter in AGS gastric cancer cells.
Höcker M; Rosenberg I; Xavier R; Henihan RJ; Wiedenmann B; Rosewicz S; Podolsky DK; Wang TC
J Biol Chem; 1998 Sep; 273(36):23046-54. PubMed ID: 9722530
[TBL] [Abstract][Full Text] [Related]
19. Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth.
Hassan M; Ghozlan H; Abdel-Kader O
Virology; 2005 Mar; 333(2):324-36. PubMed ID: 15721365
[TBL] [Abstract][Full Text] [Related]
20. Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK.
Sevilla A; Santos CR; Vega FM; Lazo PA
J Biol Chem; 2004 Jun; 279(26):27458-65. PubMed ID: 15105425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
